Drug allergy to CFTR modulator therapy associated with lumacaftor-specific CD4 + T lymphocytes

J Allergy Clin Immunol. 2021 Feb;147(2):753-756. doi: 10.1016/j.jaci.2020.05.041. Epub 2020 Jun 8.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminophenols / therapeutic use
  • Aminopyridines / adverse effects*
  • Aminopyridines / therapeutic use
  • Benzodioxoles / adverse effects*
  • Benzodioxoles / therapeutic use
  • CD4-Positive T-Lymphocytes / immunology*
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Drug Combinations
  • Drug Hypersensitivity / etiology
  • Drug Hypersensitivity / immunology*
  • Female
  • Humans
  • Quinolones / therapeutic use
  • Young Adult

Substances

  • Aminophenols
  • Aminopyridines
  • Benzodioxoles
  • CFTR protein, human
  • Drug Combinations
  • Quinolones
  • lumacaftor, ivacaftor drug combination
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • lumacaftor